Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The French National Cancer Institute (INCa) support a 28 hospital platforms network for molecular testing of cancer patients. These platforms routinely assess a panel of biomarkers in order to speed up access of French cancer patients to targeted therapies (commercially available or through clinical trials).
The objective of the BIOMARKERS-France study is to describe the epidemiological, clinical and molecular characteristics of these patients and their tumors and to assess the impact of these analyzes on their treatment (ie bio-guided therapy) as well as outcomes (response rate, progression free and overall survival).
The French National Cancer Institute (INCa) support a 28 hospital platforms network for molecular testing of cancer patients. These platforms routinely assess a panel of biomarkers in order to speed up access of French cancer patients to targeted therapies (commercially available or through clinical trials).
Regarding stage IV non-squamous NSCLC patients, 7 biomarkers are assessed including activating EGFR mutations, EML4-ALK translocation and EGFR T790M, KRAS, BRAF, HER2 and PI3KCA mutations. In 2012, up to 17 to 20,000 patients will be tested on this platform network.
The objective of the BIOMARKERS-France study is to describe the epidemiological, clinical and molecular characteristics of these patients and their tumors and to assess the impact of these analyzes on their treatment (ie bio-guided therapy) as well as outcomes (response rate, progression free and overall survival).
This study will collect, in a prospective way, data from a unique national cohort in order to guide future decisions regarding biomarker assessments (type? Number? Methods? Etc) in connexion with all the other research works currently ongoing in France.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with advanced lung cancer | Patients with advanced lung cancer |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| EGF-R gene mutation in nationwide cohort | Number of patients with EGF-R gene mutation | 1 Year |
| Measure | Description | Time Frame |
|---|---|---|
| K-RAS gene mutation in nationwide cohort | Number of patients with K-RAS gene mutation | 1 year |
| EML4-ALK translocation in nationwide cohort | Number of patients with EML4-ALK translocation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
- Histology other than NSLC
Not provided
Not provided
Not provided
Patients with advanced non-small cell cancer
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Fabrice Barlesi, PhD, MD | IFCT, Aix Marseille Université / Assistance Publique Hôpitaux de Marseille | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Clinique Calabet - Centre de Radiothérapie et d'Oncologie | Agen | France | ||||
| Clinique Claude Bernard |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33248711 | Background | Blons H, Oudart JB, Merlio JP, Debieuvre D, de Fraipont F, Audigier-Valette C, Escande F, Hominal S, Bringuier PP, Fraboulet-Moreau S, Ouafik L, Moro-Sibilot D, Lemoine A, Langlais A, Missy P, Morin F, Souquet PJ, Barlesi F, Cadranel J, Beau-Faller M; French Cooperative Thoracic Intergroup (IFCT). PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project. Lung Cancer. 2021 Jan;151:69-75. doi: 10.1016/j.lungcan.2020.11.008. Epub 2020 Nov 13. | |
| 31841714 |
| Label | URL |
|---|---|
| IFCT official website | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 1 year |
| BRAF gene mutation in nationwide cohort | Number of patients with BRAF gene mutation | 1 year |
| HER2 gene mutation in nationwide cohort | Number of patients with HER2 gene mutation | 1 year |
| PI3K gene mutation in nationwide cohort | Number of patients with PI3K gene mutation | 1 year |
| Albi |
| France |
| Clinique de l'Europe | Amiens | France |
| CHU d'Angers | Angers | France |
| Hôpital Privé d'Antony | Antony | France |
| CHIC | Aulnay-sous-Bois | France |
| Auxerre - CH | Auxerre | 89011 | France |
| CH d'Avignon | Avignon | France |
| CH de la Côte Basque | Bayonne | France |
| CHU Besancon - Pneumologie | Besançon | 25000 | France |
| CH de Béziers | Béziers | France |
| Blois - CH | Blois | 41016 | France |
| CHU Avicenne | Bobigny | France |
| Hôpital Ambroise Paré - Pneumologie | Boulogne | France |
| Hôpital Fleyriat | Bourg-en-Bresse | France |
| Hôpital de Briançon | Briançon | France |
| CHU Côte de Nâcre | Caen | France |
| Cahors - CH | Cahors | 46000 | France |
| CH de Cannes | Cannes | France |
| Chambray Les Tours - Clinique Léonard de Vinci | Chambray-lès-Tours | 37170 | France |
| CH de Chartres Hôpital Louis Pasteur | Chartres | France |
| Chevilly-Larue - CH | Chevilly-Larue | 94669 | France |
| Hôpital de Cholet - Pneumologie | Cholet | France |
| Hôpital Percy-Armées - Pneumologie | Clamart | 92140 | France |
| Hôpital Pasteur | Colmar | France |
| Clinique des Cèdres | Cornebarrieu | France |
| Créteil - CHI | Créteil | 94000 | France |
| Dax - CH | Dax | 40107 | France |
| Denain - CH | Denain | France |
| Dijon - CAC | Dijon | 21000 | France |
| Dijon - CHU | Dijon | 63000 | France |
| Draguignan - CH | Draguignan | 83300 | France |
| CH de Dreux | Dreux | France |
| Elbeuf - CH | Elbeuf | France |
| Ermont - Clinique Claude Bernard | Ermont | France |
| Epinal - CH | Épinal | 88021 | France |
| Evreux - CH | Évreux | France |
| Flers - CH | Flers | France |
| CHICAS Site de Gap | Gap | France |
| CHRU Grenoble | Grenoble | France |
| Saint Omer - CHI | Helfaut | 62570 | France |
| Jonzac - CH | Jonzac | 17500 | France |
| La Roche Sur Yon - CH | La Roche-sur-Yon | 85925 | France |
| Le Havre - HPE | Le Havre | 76700 | France |
| Le Mans - Centre Hospitalier | Le Mans | 72000 | France |
| Le Mans - Clinique Victor Hugo | Le Mans | France |
| CH Dr Schaffner de Lens | Lens | France |
| Liévin - polyclinique de Riaumont | Liévin | 62806 | France |
| CHU (Hôpital Calmette) - Pneumologie | Lille | 59000 | France |
| Lille - Hôpital Calmette | Lille | 59000 | France |
| Limoges - Hôpital du Cluzeau | Limoges | 87042 | France |
| CH de Longjumeau | Longjumeau | France |
| Lorient - CHBS | Lorient | France |
| Clinique des 4 Pavillons | Lormont | France |
| Lyon - Clinique Mutualiste | Lyon | 69003 | France |
| Clinique Mutualiste Eugène André | Lyon | France |
| HIA Desgenettes | Lyon | France |
| Hôpital de la Croix Rousse | Lyon | France |
| Lyon - Hôpital Louis Pradel (Pneumologie) | Lyon | France |
| Mantes La Jolie - CH | Mantes-la-Jolie | 78200 | France |
| Marseille - Hôpital Sainte Marguerite | Marseille | 13000 | France |
| Marseille - CRLCC | Marseille | France |
| Polyclinique du Parc | Maubeuge | France |
| Meaux - CH | Meaux | 77100 | France |
| Metz - CHR | Metz | 57000 | France |
| Metz - Clinique Claude Bernard | Metz | 57000 | France |
| Metz - Belle Isle | Metz | France |
| Mont de Marsan - CH | Mont-de-Marsan | 40000 | France |
| Montpellier - Clinique Clémentville | Montpellier | 34070 | France |
| Montpellier - CHRU | Montpellier | 34295 | France |
| Moulins - CH | Moulins | 03000 | France |
| Mulhouse - CH | Mulhouse | 68000 | France |
| CHU Nancy | Nancy | France |
| Nancy - Polyclinique Gentilly | Nancy | France |
| Nanterre - CH | Nanterre | 92014 | France |
| Nantes - Centre René Gauducheau | Nantes | 44805 | France |
| Hôpital Laënnec - CHU de Nantes | Nantes | France |
| Narbonne - Polyclinique Le Languedoc | Narbonne | France |
| Neuilly - Hôpital Américain de Paris | Neuilly | 92200 | France |
| Nevers - CH | Nevers | 58033 | France |
| Nice - CAC | Nice | 06000 | France |
| Nîmes - Clinique Valdegour | Nîmes | 30900 | France |
| CHU | Nîmes | France |
| Orléans - CH | Orléans | 45000 | France |
| Paris - Saint Louis | Paris | 75000 | France |
| Paris - hôpital Saint-Antoine | Paris | 75012 | France |
| GH Paris Saint-Joseph | Paris | France |
| Hôpital Bichat - Claude - Bernard | Paris | France |
| Hôpital du Val de Grâce | Paris | France |
| Hôpital Européen Georges Pompidou | Paris | France |
| Hôpital Tenon | Paris | France |
| Paris - Curie | Paris | France |
| Pau - CH | Pau | 64046 | France |
| Perpignan - Centre Catalan d'Oncologie | Perpignan | 66000 | France |
| Perpignan - Ch | Perpignan | 66046 | France |
| CH de Périgueux | Périgueux | France |
| Lyon Sud | Pierre-Bénite | 69495 | France |
| CHU | Poitiers | France |
| Pontoise - CH | Pontoise | France |
| Reims - CHU | Reims | 51092 | France |
| Reims - CRLCC | Reims | France |
| Rennes - CHU | Rennes | 35033 | France |
| CHG de Roanne | Roanne | France |
| Rodez - CH | Rodez | 12021 | France |
| Roncq - Clinique Saint-Roch | Roncq | 59223 | France |
| Roubaix - CH | Roubaix | 59100 | France |
| Rouen - CHU | Rouen | 76000 | France |
| Centre Frederic Joliot | Rouen | France |
| Saint Brieuc - CHG | Saint-Brieuc | 22000 | France |
| Saint Nazaire - Centre Etienne Dolet | Saint-Nazaire | 44600 | France |
| Saint-Nazaire - CH | Saint-Nazaire | France |
| Saint Priest en Jarez - ICL | Saint-Priest-en-Jarez | 42270 | France |
| Saint Quentin - CH | Saint-Quentin | 02100 | France |
| Saverne - CH | Saverne | France |
| Senlis - CH | Senlis | 60300 | France |
| Saint-Malo - CH | St-Malo | 35403 | France |
| Strasbourg - NHC | Strasbourg | 63000 | France |
| Suresnes - Hopital Foch | Suresnes | 92151 | France |
| Thonon les bains | Thonon-les-Bains | 74200 | France |
| Toulon - CHI | Toulon | 83000 | France |
| Toulon - HIA | Toulon | 83000 | France |
| Clinique Saint Jean du Languedoc | Toulouse | France |
| Toulouse - CHU Larrey | Toulouse | France |
| Toulouse - Clinique Pasteur | Toulouse | France |
| Tours - CHU | Tours | 37000 | France |
| Troyes - CH | Troyes | 10000 | France |
| Valenciennes - Clinique | Valenciennes | 59304 | France |
| Verdun - CHG | Verdun | France |
| Vesoul - CHI | Vesoul | 70000 | France |
| CHI de la Haute-Saône - Pneumologie | Vesoul | France |
| Clinique Mutualiste Les Portes du Sud | Vénissieux | France |
| Vienne - CH | Vienne | 38200 | France |
| Villejuif - Institut Gustave Roussy | Villejuif | 94800 | France |
| Background |
| Beau-Faller M, Pencreach E, Leduc C, Blons H, Merlio JP, Bringuier PP, de Fraipont F, Escande F, Lemoine A, Ouafik L, Denis M, Hofman P, Lacave R, Melaabi S, Langlais A, Missy P, Morin F, Moro-Sibilot D, Barlesi F, Cadranel J; French Cooperative Thoracic Intergroup (IFCT). Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project. Lung Cancer. 2020 Feb;140:19-26. doi: 10.1016/j.lungcan.2019.10.013. Epub 2019 Nov 15. |
| 28945865 | Background | Leduc C, Merlio JP, Besse B, Blons H, Debieuvre D, Bringuier PP, Monnet I, Rouquette I, Fraboulet-Moreau S, Lemoine A, Pouessel D, Mosser J, Vaylet F, Langlais A, Missy P, Morin F, Moro-Sibilot D, Cadranel J, Barlesi F, Beau-Faller M; French Cooperative Thoracic Intergroup (IFCT). Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program. Ann Oncol. 2017 Nov 1;28(11):2715-2724. doi: 10.1093/annonc/mdx404. |
| 32609781 | Background | Kembou Nzale S, Weeks WB, Ouafik L, Rouquette I, Beau-Faller M, Lemoine A, Bringuier PP, Le Coroller Soriano AG, Barlesi F, Ventelou B. Inequity in access to personalized medicine in France: Evidences from analysis of geo variations in the access to molecular profiling among advanced non-small-cell lung cancer patients: Results from the IFCT Biomarkers France Study. PLoS One. 2020 Jul 1;15(7):e0234387. doi: 10.1371/journal.pone.0234387. eCollection 2020. |
| 36180314 | Background | Mordant P MD, PhD, Brosseau S, Milleron B, Santelmo N, Fraboulet-Moreau S, Besse B, Langlais A, Gossot D, Thomas PA, Pujol JL, Ricordel C, Madelaine J, Lamy R, Audigier-Valette C, Missy P, Blons H, Barlesi F, Westeel V; French Cooperative Thoracic Intergroup (IFCT). Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study. Clin Lung Cancer. 2023 Jan;24(1):1-10. doi: 10.1016/j.cllc.2022.08.013. Epub 2022 Aug 29. |
| 28189832 | Background | Guibert N, Barlesi F, Descourt R, Lena H, Besse B, Beau-Faller M, Mosser J, Pichon E, Merlio JP, Ouafik L, Guichard F, Mastroianni B, Moreau L, Wdowik A, Sabourin JC, Lemoine A, Missy P, Langlais A, Moro-Sibilot D, Mazieres J. Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers France. J Thorac Oncol. 2017 Jun;12(6):963-973. doi: 10.1016/j.jtho.2017.02.001. Epub 2017 Feb 9. |
| 31181537 | Background | Couraud S, Barlesi F, Fontaine-Deraluelle C, Debieuvre D, Merlio JP, Moreau L, Beau-Faller M, Veillon R, Mosser J, Al Freijat F, Bringuier PP, Lena H, Ouafik L, Westeel V, Morel A, Audigier-Valette C, Missy P, Langlais A, Morin F, Souquet PJ, Planchard D; Biomarkers France Contributors. Clinical outcomes of non-small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France study. Eur J Cancer. 2019 Jul;116:86-97. doi: 10.1016/j.ejca.2019.04.016. Epub 2019 Jun 8. |
| 34589947 | Background | Ruppert AM, Beau-Faller M, Debieuvre D, Ouafik L, Westeel V, Rouquette I, Mazieres J, Bringuier PP, Monnet I, Escande F, Ricordel C, Merlio JP, Janicot H, Lemoine A, Foucher P, Poudenx M, Morin F, Langlais A, Souquet PJ, Barlesi F, Wislez M. Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancerologie Thoracique Biomarkers France Study by KRAS Mutation Subtypes. JTO Clin Res Rep. 2020 May 15;1(3):100052. doi: 10.1016/j.jtocrr.2020.100052. eCollection 2020 Sep. |
| 28798090 | Background | Tomasini P, Brosseau S, Mazieres J, Merlio JP, Beau-Faller M, Mosser J, Wislez M, Ouafik L, Besse B, Rouquette I, Debieuvre D, Escande F, Westeel V, Audigier-Valette C, Missy P, Langlais A, Morin F, Moro-Sibilot D, Zalcman G, Barlesi F. EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice. Eur Respir J. 2017 Aug 10;50(2):1700514. doi: 10.1183/13993003.00514-2017. Print 2017 Aug. |
| 26777916 | Result | Barlesi F, Mazieres J, Merlio JP, Debieuvre D, Mosser J, Lena H, Ouafik L, Besse B, Rouquette I, Westeel V, Escande F, Monnet I, Lemoine A, Veillon R, Blons H, Audigier-Valette C, Bringuier PP, Lamy R, Beau-Faller M, Pujol JL, Sabourin JC, Penault-Llorca F, Denis MG, Lantuejoul S, Morin F, Tran Q, Missy P, Langlais A, Milleron B, Cadranel J, Soria JC, Zalcman G; Biomarkers France contributors. Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT). Lancet. 2016 Apr 2;387(10026):1415-1426. doi: 10.1016/S0140-6736(16)00004-0. Epub 2016 Jan 15. |
| ID | Term |
|---|---|
| D002289 | Carcinoma, Non-Small-Cell Lung |
| D008175 | Lung Neoplasms |
| ID | Term |
|---|---|
| D002283 | Carcinoma, Bronchogenic |
| D001984 | Bronchial Neoplasms |
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided